...
首页> 外文期刊>Journal of chemical information and modeling >Incorporating Multisource Knowledge To Predict Drug Synergy Based on Graph Co-regularization
【24h】

Incorporating Multisource Knowledge To Predict Drug Synergy Based on Graph Co-regularization

机译:包含多源知识以预测基于图形共规则的药物协同作用

获取原文
获取原文并翻译 | 示例
           

摘要

Drug combinations may reduce toxicity and increase therapeutic efficacy, offering a promising strategy to conquer multiple complex diseases. However, due to large-scale combinatorial space, it remains challenging to identify effective combinations. Although many computational methods have focused on predicting drug synergy to reduce combinatorial space, they fail to effectively consider multiple sources of important knowledge. Thus, it is necessary to propose a computational method that can exploit useful information to predict drug synergy. Here, we developed a computational method to predict drug synergy based on graph co-regularization, named DSGCR. By incorporating drug-target network patterns, pharmacological patterns, and prior knowledge of drug combinations, DSGCR performs predictions of synergistic drug combinations. Compared to several existing methods, DSGCR achieves superior performance in predicting drug synergy in terms of various metrics via cross-validation. Additionally, we analyzed the importance of various sources of drug knowledge concerning three DSGCRs scenarios. Finally, the potential of DSGCR to score drug synergy was confirmed by three predicted synergistic drug combinations.
机译:药物组合可以减少毒性并提高治疗效果,提供了征服多种复杂疾病的有希望的策略。然而,由于大规模的组合空间,确定有效组合仍然具有挑战性。虽然许多计算方法都集中在预测药物协同作用以减少组合空间,但它们未能有效地考虑多种重要知识的来源。因此,有必要提出一种可以利用有用信息来预测药物协同作用的计算方法。在这里,我们开发了一种计算方法,以预测基于图形共规则的药物协同作用,名为DSGCR。通过纳入药物 - 目标网络模式,药理模式和药物组合的先验知识,DSGCR执行协同药物组合的预测。与几种现有方法相比,DSGCR通过交叉验证在各种指标方面取得了卓越的性能。此外,我们分析了有关三个DSGCR方案的各种药物知识来源的重要性。最后,通过三种预测协同药物组合确认了DSGCR以评分药物协同作用的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号